Clinical Trial Update: Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of an Organon investigational drug for familial hypercholesterolemia and sitosterolemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Sitosterolemia

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia, Familial, Lipid Metabolism, Inborn Errors | Phase 3 | Status: TERMINATED